Imaging and histomorphometric evaluation of mandible and tibia of rats treated with bisphosphonates

• Published in: Oral and maxillofacial surgery Vol. 23; no. 4; pp. 473 - 479
• Main Authors: Martelli, Stephanie Joana Roman, Damian, Melissa Feres, Schinestsck, André Ribeiro, Schuch, Lauren Frenzel, Cascaes, Andreia Morales, Vasconcelos, Ana Carolina Uchoa
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.12.2019; Springer Nature B.V
• Subjects: Acids; Bisphosphonates; Bone marrow; Dentistry; Family medical history; Jaw; Laboratory animals; Medicine; Medicine & Public Health; Oral and Maxillofacial Surgery; Original Article; Patients; Rodents; Jaws; Bisphosphonate-associated osteonecrosis of the jaw; Bisphosphonate; Bone tissue; Cone-beam computed tomography
• ISSN: 1865-1550; 1865-1569
• DOI: 10.1007/s10006-019-00807-9

Objectives To evaluate the mandible and tibia of rats treated with bisphosphonates (BPs) by imaging and histomorphometric analysis. Study design Thirty-four rat specimens ( Rattus norvegicus , Wistar strain) were distributed into 3 groups: (1) 12 rats treated with zoledronic acid; (2) 12 rats treated with clodronate; and (3) the control group, containing 10 rats that received saline. All bones were exposed to cone beam computed tomography (CBCT). The images were analyzed to determine bone density (BD), using the software OsiriX 7.0. Histological slides were prepared from the specimens and the proportion of bone volume (BV) was quantified using the software Adobe Photoshop CC. Results There was no statistically significant difference in BD either between the drug groups or between mandible and tibia. BV between BPs and control group did not show a significant difference. However, comparing the two bones, the mandibles in the control group displayed higher BV than did the tibiae in the same group. Conclusion According to our results, we conclude that (1) BD was not altered by bone type or by type of BP administered, and (2) treatment with zoledronic acid or clodronate did not affect BV in the mandible or tibia of test groups.